Live news , top stories, corporate news, company news, sector news, economy news, results analysis news, ceo interviews, fund manager interview, advisor interview, market news, bazaar talk, hot stocks news, ipo news, commodities news, mutual fund news, insurance news, news wire
16 July, 2018 12:13 IST
Lupin gets tentative USFDA approval for Testosterone gel
Source: IRIS | 17 Apr, 2018, 04.06PM
Comments  |  Post Comment

Pharma major Lupin announced that it has received tentative approval for its Testosterone Gel, 1.62% (20.25 mg/1.25 gm actuation) from the United States Food and Drug Administration (FDA) to market a generic version of AbbVie Inc.'s AndraGel®, 1.62%.

Lupin's Testosterone Gel, 1.62% (20.25 mg/1.25 gm actuation) is the generic equivalent of AbbVie Inc.'s AndroGel®, 1.62%. It is indicated for replacement therapy in males for conditions associated with a deficiency or absence of endogenous testosterone: Primary hypogonadism (congenital or acquired) and Hypogonadotropic hypogonadism (congenital or acquired).

Testosterone Gel, 1.62% (20.25 mg/1.25 gm actuation) had annual sales of approximate USD 956.9 million in the US (IQVIA MAT January 2018).

Shares of the company gained Rs 22.95, or 2.94%, to settle at Rs 804.30. The total volume of shares traded was 128,567 at the BSE (Tuesday).



Lupin Limited   (Q,N,C,F)*

Comments Post comment 
 Post Comment
Name Email
Comment
Security Code type    into this box
Company Update
Minda Ind approves acquisition of 80% stake in iSVS RTS GmbH, forms JV with Japan's Kosei - 16-Jul-2018 11:47
Lupin's Goa facility gets approval from UK MHRA - 16-Jul-2018 11:22
Suven Life Sciences secures product patents in Europe and South Korea - 16-Jul-2018 11:18
GAIL update on Varanasi City Gas Distribution network - 16-Jul-2018 10:56
Moody's downgrades Tata Motors to Ba2 - 16-Jul-2018 09:54
Infosys Q1 profit rises 4% y-o-y to Rs 36.12 bn - 13-Jul-2018 16:45
Fortis accepts Rs 40 bn investment offer from IHH Healthcare Berhad - 13-Jul-2018 10:38
White Organic Agro receives export order for 65 MT of cluster beans - 13-Jul-2018 09:51
Vakrangee partners with Reliance Nippon Life Asset Management - 13-Jul-2018 09:47
Larsen & Toubro wins orders worth Rs 30 bn - 13-Jul-2018 09:41
Cadila Healthcare's JV facility of Zydus Hopsira Oncology receives EIR from USFDA - 12-Jul-2018 13:23
more...
Home  |   Shares  |   F&O  |   Mutual Funds  |   Loans  |   Insurance  |   News Centre
Wealth Tracker  |   Newsletters  |   Tax Corner  |   NRI Centre  |   Advertise
© All rights reserved. IRIS Business Services Limited
A Disclaimer